These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2693032)

  • 1. Protective effect of probucol on alloxan diabetes in rats.
    Matsushita M; Yoshino G; Iwai M; Matsuba K; Morita M; Iwatani I; Yoshida M; Kazumi T; Baba S
    Diabetes Res Clin Pract; 1989 Nov; 7(4):313-6. PubMed ID: 2693032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of antioxidant enzymes and antioxidant compound probucol in antiradical protection of pancreatic beta-cells during alloxan-induced diabetes.
    Lankin VZ; Korchin VI; Konovalova GG; Lisina MO; Tikhaze AK; Akmaev IG
    Bull Exp Biol Med; 2004 Jan; 137(1):20-3. PubMed ID: 15085236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo protective effect of Ganoderma lucidum polysaccharides on alloxan-induced pancreatic islets damage.
    Zhang HN; He JH; Yuan L; Lin ZB
    Life Sci; 2003 Sep; 73(18):2307-19. PubMed ID: 12941433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of probucol on recovery from streptozotocin diabetes in rats.
    Yoshino G; Matsushita M; Maeda E; Morita M; Nagata K; Matsuba K; Tani T; Horinuki R; Kimura Y; Kazumi T
    Horm Metab Res; 1992 Jul; 24(7):306-9. PubMed ID: 1516883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible role for the thioredoxin system in the protective effects of probucol in the pancreatic islets of diabetic rats.
    Liu JH; Liu DF; Wang NN; Lin HL; Mei X
    Clin Exp Pharmacol Physiol; 2011 Aug; 38(8):528-33. PubMed ID: 21615774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of phenol antioxidants on the development of alloxan diabetes in rats].
    Bobyreva LE
    Eksp Klin Farmakol; 1997; 60(3):51-3. PubMed ID: 9324400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effects of retinyl palmitate on streptozotocin- and alloxan-induced beta cell toxicity and diabetes in the rat.
    Chertow BS; Webb MD; Leidy JW; Cordle MB
    Res Commun Chem Pathol Pharmacol; 1989 Jan; 63(1):27-44. PubMed ID: 2521747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Protective effect of verapamil against alloxan-induced damage on pancreatic islet beta-cells in rats].
    Wei YJ; Yu GZ; Zhang GF; Yu JR
    Sheng Li Xue Bao; 1992 Apr; 44(2):209-14. PubMed ID: 1621112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction in the diabetogenic effect of alloxan in mice by treatment with the antineoplastic agent ICRF-187.
    El-Hage AN; Herman EH; Ferrans VJ
    Res Commun Chem Pathol Pharmacol; 1981 Sep; 33(3):509-23. PubMed ID: 7036302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of diabetogenic compounds: cyproheptadine and alloxan.
    Chatterjee AK; Varayotha V; Fischer LJ
    Fundam Appl Toxicol; 1991 Jan; 16(1):188-97. PubMed ID: 2019344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal B-cell function in neonatally streptozotocin-diabetic rats: insensitivity to alloxan toxicity.
    Grill V; Westberg M
    Endocrinology; 1987 Dec; 121(6):2171-6. PubMed ID: 2445559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetogenic action of alloxan-like compounds: cytotoxic effects of 5-hydroxy-pseudouric acid and dehydrouramil hydrate hydrochloride on rat pancreatic beta cells.
    Dominis M; Rocic S; Ashcroft SJ; Rocic B; Poje M
    Diabetologia; 1984 Sep; 27(3):403-6. PubMed ID: 6389244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of probucol on development of diabetes mellitus in BB rats.
    Drash AL; Rudert WA; Borquaye S; Wang R; Lieberman I
    Am J Cardiol; 1988 Jul; 62(3):27B-30B. PubMed ID: 3394650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probucol partially prevents development of diabetes in NOD mice.
    Uehara Y; Shimizu H; Sato N; Shimomura Y; Mori M; Kobayashi I
    Diabetes Res; 1991 Jul; 17(3):131-4. PubMed ID: 1841028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of probucol on the development of non-insulin dependent diabetes mellitus in Otsuka Long Evans Tokushima Fatty (OLETF) rats.
    Ishida K; Shi K; Mizuno A; Sano T; Shima K
    Tokushima J Exp Med; 1994 Jun; 41(1-2):41-7. PubMed ID: 7940531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance of ALR/Lt islets to free radical-mediated diabetogenic stress is inherited as a dominant trait.
    Mathews CE; Leiter EH
    Diabetes; 1999 Nov; 48(11):2189-96. PubMed ID: 10535453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of rhIL-1beta on pancreatic islets of alloxan-induced diabetic rats.
    Wu LP; Chen LH; Zhang JS; Sun L; Zhang YQ
    World J Gastroenterol; 2004 Nov; 10(22):3353-5. PubMed ID: 15484317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Protective effect of indomethacin on alloxan-induced diabetes in rat].
    Xu WX; Yu JR
    Sheng Li Xue Bao; 1992 Apr; 44(2):202-8. PubMed ID: 1621111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antioxidant MDL 29,311 prevents diabetes in nonobese diabetic and multiple low-dose STZ-injected mice.
    Heineke EW; Johnson MB; Dillberger JE; Robinson KM
    Diabetes; 1993 Dec; 42(12):1721-30. PubMed ID: 8243818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The protective role of copper-zinc superoxide dismutase against alloxan-induced diabetes: morphological aspects.
    Thaete LG; Crouch RK; Buse MG; Spicer SS
    Diabetologia; 1985 Sep; 28(9):677-82. PubMed ID: 3905479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.